Licochalcone A inhibits glioma migration, invasion, and growth by triggering mitochondrial dysfunction and

Chao Yu1,2, Deyan Yang3, Nannan Li4

  • 1Department of Pain Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, 271000, Shandong, China.

Insights

Licochalcone A (Lic-A) effectively inhibits glioma cell growth, migration, and invasion. This natural compound induces apoptosis and oxidative stress, offering a promising avenue for glioma treatment.

Area of Science:

  • Neuro-oncology
  • Pharmacology

Background:

  • Glioma is a prevalent and aggressive central nervous system malignancy with limited therapeutic options.
  • Licochalcone A (Lic-A), a flavonoid from Glycyrrhiza, exhibits potential anti-tumor properties.

Purpose of the Study:

  • To evaluate the anti-glioma efficacy of Licochalcone A (Lic-A) in vitro and in vivo.
  • To elucidate the underlying mechanisms of Lic-A's anti-tumor activity in glioma.

Main Methods:

  • In vitro studies assessed glioma cell proliferation, migration, and invasion.
  • Mitochondrial function, Bcl-2 family regulation, and reactive oxygen species (ROS) generation were analyzed.
  • In vivo experiments utilized animal models to confirm Lic-A's effect on glioma growth.

Main Results:

  • Lic-A significantly inhibited glioma cell growth, migration, and invasion in a dose-dependent manner.
  • Lic-A induced mitochondrial dysfunction and apoptosis, mediated by ROS production.
  • ROS inhibition exacerbated glioma cell migration and invasion, highlighting the role of oxidative stress.
  • In vivo studies confirmed Lic-A's ability to suppress glioma tumor growth.

Conclusions:

  • Licochalcone A demonstrates significant anti-glioma activity by inhibiting cell migration and invasion.
  • The anti-tumor effects of Lic-A are linked to the induction of glioma cell apoptosis and oxidative stress, potentially via ATM/ATR pathway activation.